Scienture Holdings/$SCNX
1D1W1MYTD1Y5YMAX
Capital at risk
About Scienture Holdings
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
- Ticker
- $SCNX
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 7
- Headquarters
- Commack, United States
- Website
- scienture.com
SCNX Metrics
BasicAdvanced
$13M
-
-$1.30
3.96
-
Price and volume
Market cap
$13M
Beta
3.96
52-week high
$2.60
52-week low
$0.24
Average daily volume
2.6M
Financial strength
Current ratio
3.041
Quick ratio
2.833
Long term debt to equity
0.149
Total debt to equity
0.167
Interest coverage (TTM)
-4.48%
Profitability
EBITDA (TTM)
-12.361
Gross margin (TTM)
87.72%
Net profit margin (TTM)
-4,620.92%
Operating margin (TTM)
-1,671.11%
Effective tax rate (TTM)
4.99%
Revenue per employee (TTM)
$120,000
Management effectiveness
Return on assets (TTM)
-8.93%
Return on equity (TTM)
-53.47%
Valuation
Price to revenue (TTM)
11.159
Price to book
0.2
Price to tangible book (TTM)
-2.16
Price to free cash flow (TTM)
-0.635
Free cash flow yield (TTM)
-157.57%
Free cash flow per share (TTM)
-0.494
Growth
Revenue change (TTM)
540.64%
Earnings per share change (TTM)
-44.14%
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.